Genomic Vaccination

Vaccination consists of appealing the system with a contagious agent, or elements of a contagious agent, changed in such a fashion that there's no damage or sickness, however securing that once the host is resisted thereupon contagious agent, the system will fittingly neutralize it before it causes any health problem. 100 years vaccination has been bring out by one among 2 match: either introducing specific antigens against that the system reacts directly; or introducing live attenuated infectious agents that replicate inside the host while not inflicting sickness synthesize the antigens that afterwards prime the system.

 

  • No risk for infection
  • Antigen presentation by both MHC class I and class II molecules
  • Polarise T-cell response toward type 1 or type 2

Related Conference of Genomic Vaccination

September 27-28, 2021

15th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
October 18-19, 2021

20th International Conference on Structural Biology

Rome, Italy
November 20-21, 2021

26th World Congress on Industrial Biotechnology

Chicago, USA
November 24-25, 2021

3rd Annual summit on Cell Signaling and Cancer Therapy

Vancouver, Canada
December 07-08, 2021

2nd World Congress on Cell and Structural Biology

Sydney, Australia
December 09-10, 2021

2nd International Conference on Geriatrics and Ageing

Sydney, Australia
March 10-11, 2022

14th World Congress on Stem Cell Research

Paris, France
April 14-15, 2022

15th World Conference on Human Genomics and Genomic Medicine

Singapore City, Singapore
April 14-15, 2022

9th World Congress on Human Genetics and Genetic Diseases

Singapore City, Singapore
April 29-30, 2022

26th Global Congress on Biotechnology

Vienna, Austria

Genomic Vaccination Conference Speakers

Recommended Sessions

Related Journals

Are you interested in